AnalystsIrina Rivkind KofflerIrina Rivkind Koffler's Stock Forecasts
AnalystsIrina Rivkind Koffler
Analyst Ranking
Bottom 10%
#4413 out of 4870 analysts
Average Return
-25.66%
Win Rate
23%3 out of 13
Risk vs Reward
Poor
Good
Irina Rivkind Koffler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adamas Pharmaceuticals IncADMS | +53.06% | $8.16 | $3.83 | 2019-03-04 - 2020-03-05 | Sell |
Horizon Therapeutics Public Ltd CoHZNP | +39.99% | $15.18 | $21.25 | 2018-01-11 - 2018-11-15 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +5.47% | $32.19 | $30.43 | 2017-02-09 - 2017-06-15 | Sell |
Irina Rivkind Koffler Analyst Color
Get additional color on Irina Rivkind Koffler's coverage of popular stocks
Irina Rivkind Koffler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eagle Pharmaceuticals IncEGRX | 2 | Hold | $41.00 | N/A | Maintains | 6 years ago |
Evolus IncEOLS | 2 | Strong Buy | $29.00 | N/A | Maintains | 6 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Sell | $5.00 | N/A | Downgrades | 6 years ago |
Pacira Biosciences IncPCRX | 2 | Sell | N/A | N/A | Downgrades | 6 years ago |
Supernus Pharmaceuticals IncSUPN | 2 | Strong Buy | $63.00 | N/A | Maintains | 6 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $21.00 | N/A | Downgrades | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 5 | Strong Buy | $29.00 | N/A | Maintains | 7 years ago |
Allergan PLCAGN | 2 | Hold | $176.00 | N/A | Maintains | 7 years ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Endo International PLCENDPQ | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Dermira IncDERM2 | 2 | Hold | $9.00 | N/A | Downgrades | 7 years ago |
Sucampo Pharmaceuticals IncSCMP | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Hold | $150.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.